National Use Patterns and Comparative Effectiveness of Extracorporeal Membrane Oxygenation in Myocardial Infarction–Related Cardiogenic Shock
Journal of the American Heart Association · 03.11.2026 · 15 (21)
DOI: 10.1161/jaha.126.049443 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 03.11.2026. Verfasst von Ajar Kochar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Richard and Susan Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Shock, Cardiogenic, Myocardial Infarction. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Extracorporeal membrane oxygenation (ECMO) provides bi‐ventricular support for patients with myocardial infarction–related cardiogenic shock (MI‐CS); comparative effectiveness data relative to other mechanical circulatory support remain limited. We characterize contemporary ECMO utilization for MI‐CS and compare short‐term mortality across ECMO and non‐ECMO treatment strategies.
Methods
We compared baseline characteristics and temporal trends in mechanical circulatory support utilization among Medicare beneficiaries hospitalized with MI‐CS from 2016 to 2023 and treated with ECMO, Impella, intra‐aortic balloon pump, or medical management alone. Patient outcomes for each group were evaluated using inverse probability of treatment weighting, G‐formula approach, and grace period analysis. The primary endpoint was 30‐day all‐cause mortality.
Results
The cohort included 102 718 patients: 1165 (1.1%) treated with ECMO, 10 064 (9.8%) Impella, 24 631 (24.0%) intra‐aortic balloon pump, and 66 858 (65.1%) medical management alone. From 2016 to 2023, ECMO use for MI‐CS increased from 0.8% to 1.8%. The percentage of hospitals using ECMO increased from 9.2% to 17.1%. Unadjusted 30‐day mortality was higher for ECMO (69%) compared with Impella (60%), intra‐aortic balloon pump (39%), and medical management (46%) (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Richard and Susan Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA.
- Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA USA.
- Division of Cardiology Beth Israel Deaconess Medical Center Boston MA USA.
- Food and Drug Administration Washington DC USA.
- The Cardiovascular Center Tufts Medical Center Boston MA USA.
- Copenhagen University Hospital Rigshospitalet Copenhagen Denmark.
ORCID-Profile: Ajar Kochar, Christina Lalani, Yang Song, Zaid Almarzooq, Changfu Wu, Navin K Kapur, Jacob E Moller, Eric A Secemsky, Arthur R Garan, Robert W Yeh
Zitieren
APA
Kochar, A., Lalani, C., Song, Y., Almarzooq, Z., Farb, A., Wu, C., Zuckerman, B., Kapur, N. K., Moller, J. E., Secemsky, E. A., Garan, A. R., & Yeh, R. W. (2026). National Use Patterns and Comparative Effectiveness of Extracorporeal Membrane Oxygenation in Myocardial Infarction–Related Cardiogenic Shock. Journal of the American Heart Association, 15(21). https://doi.org/10.1161/jaha.126.049443
Vancouver
Kochar A, Lalani C, Song Y, Almarzooq Z, Farb A, Wu C, et al. National Use Patterns and Comparative Effectiveness of Extracorporeal Membrane Oxygenation in Myocardial Infarction–Related Cardiogenic Shock. Journal of the American Heart Association. 2026;15(21). doi:10.1161/jaha.126.049443
BibTeX
@article{Kochar2026,
author = {Kochar, Ajar and Lalani, Christina and Song, Yang and Almarzooq, Zaid and Farb, Andrew and Wu, Changfu and Zuckerman, Bram and Kapur, Navin K and Moller, Jacob E and Secemsky, Eric A and Garan, Arthur R and Yeh, Robert W},
title = {National Use Patterns and Comparative Effectiveness of Extracorporeal Membrane Oxygenation in Myocardial Infarction–Related Cardiogenic Shock},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {21},
doi = {10.1161/jaha.126.049443}
}
EUVIMED